|
|
|
|
| Advertisement |
 |
|
| Advertisement |
Minimizing the Negative Impact of Sales Rep Vacancies
The impact of vacant sales territories on overall brand performance is often underestimated within pharma and biotech companies. There are varying causes of vacancies, including rep promotions and transfers, resignations, terminations, and organizational restructuring. These vacancies have significant impact on pharma and biotech brands.
Read the Article
|
| Strategy |
|
| Technology |
|
| REGULATORY |
 |
|
PDPRA’s Operational Challenges |
Whether or not the new Prescription Drug Pricing Reduction Act (PDPRA) is a good policy, if it is enacted, its proposals have to work as intended and ensure compliant operationalization, writes Jeremy Docken
… /Read more/ |
|
|
|
|
|
|
|
|
|
/ March 8-11, 2020: Pharma Forum 2020
/ |
|
New York City, NY |
|
/ March 30–31, 2020: 6th Edition Drug Pricing Transparency Congress
/ |
|
Philadelphia, PA |
|
/ March 31–April 2, 2020: eyeforpharma Barcelona 2020
/ |
|
Barcelona, Spain |
|
/ April 20–22, 2020: Digital Health for Pharma
/ |
|
Philadelphia, PA. |
|
/ April 22¬–24: 9th Digital Marketing for Medical Devices West
/ |
|
Burlingame, CA |
|
/ April 29–May 1, 2020: Pharmaceutical Compliance Congress (PCC) 2020
/ |
|
Washington, D.C. |
|
/ June 14–18, 2020: DIA 2020 Global Annual Meeting
/ |
|
Washington, D.C. |
|
June 15–17: BePharma 2020
/ |
|
Mexico City, Mexico |
|
/ June 16–17: Financial Strategies and Accounting
/ |
|
San Francisco, CA |
|
/ June 16–18: Patient Support Services Congress
/ |
|
Philadelphia, PA |
 |
|
| |
|
|
|
|
| Industry update |
| //ORIC Pharmaceuticals (San Francisco, CA), a clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced the appointment of Mardi C. Dier to its Board of Directors. Ms. Dier currently serves as EVP, CFO and Chief Business Officer of Portola Pharmaceuticals.
//
Amplity Health (Yardley, PA), announced the election of Anthony C. Hooper, former Executive Vice President of Global Commercial Operations at Amgen, to its Board of Directors.
//
Andre Heeg became a partner in the Berlin office of Boston Consulting Group Digital Ventures (BCGDV). Heeg was previously Global Head of Digitization at Novartis subsidiary Sandoz.
|
|
|
|
|
|
|
|
|
|
|
